They finally construct endogenous CD38 knockdown CAR NK cells with promising success in minimizing NK cell fratricide and specifically killing CD38+ acute myeloid leukemia (AML) cell lines and primary leukemia cells [140]. This evidence concerns the gene CD38 and acute myeloid leukemia.